Quantification of pulmonary involvement in COVID-19 pneumonia by means of a cascade of two U-nets: training and assessment on multiple datasets using different annotation criteria - Scorecard - MDSpire
Advertisement
Quantification of pulmonary involvement in COVID-19 pneumonia by means of a cascade of two U-nets: training and assessment on multiple datasets using different annotation criteria
Clinical Scorecard: Assessment of Lung Involvement in COVID-19 Pneumonia Using a Dual U-Net Approach: Training and Evaluation Across Various Datasets with Distinct Annotation Standards
At a Glance
Category
Detail
Condition
COVID-19 pneumonia with lung parenchyma abnormalities
Key Mechanisms
Deep Learning-based segmentation of lung and COVID-19 lesions on CT scans using a dual U-Net architecture
Target Population
Patients with COVID-19 infection undergoing chest CT imaging
Care Setting
Radiology and diagnostic imaging settings with CT scan availability
Key Highlights
COVID-19 lung abnormalities include bilateral ground-glass opacifications, consolidations, crazy-paving patterns, reversed halo sign, and vascular enlargement.
The LungQuant system uses a cascade of two U-Nets: the first segments lungs, the second segments COVID-19 lesions, providing quantitative lung involvement and CT severity score (CT-SS).
Training on heterogeneous, publicly available datasets with different annotation standards improves generalization of the DL segmentation model.
Guideline-Based Recommendations
Diagnosis
Use chest CT imaging to identify COVID-19 related lung abnormalities including GGO and consolidations.
Apply automated DL-based segmentation tools like LungQuant to quantify lung involvement objectively.
Management
Utilize quantitative lung lesion volume and CT-SS from segmentation outputs to assist clinical decision-making and disease severity assessment.
Monitoring & Follow-up
Monitor changes in lung lesion volume and CT-SS over time using serial CT scans and DL segmentation to evaluate disease progression or resolution.
Risks
Variability in CT acquisition protocols and annotation standards can affect segmentation accuracy.
Data conversion processes (e.g., DICOM to NifTI) may reduce image resolution and impact quantitative analysis.
Patient & Prescribing Data
Patients with confirmed or suspected COVID-19 undergoing chest CT
Quantitative assessment of lung involvement via DL segmentation may guide treatment intensity and monitor response but requires validation in clinical workflows.
Clinical Best Practices
Train DL segmentation models on large, heterogeneous datasets to improve robustness and generalizability.
Use dual-stage U-Net architecture: first for lung segmentation, second for lesion segmentation within lung regions.
Incorporate morphology-based refinement post lung segmentation to improve mask accuracy.
Calculate CT severity score based on percentage of lung volume affected by lesions to standardize severity assessment.